stockrowNeuroPace, Inc. (NPCE) vs Shoulder Innovations, Inc. (SI)
- NeuroPace, Inc. NPCE 12.38 −2.44%
- Shoulder Innovations, Inc. SI 20.06 −1.52%
NeuroPace, Inc. and Shoulder Innovations, Inc. are both Medical Devices companies. NeuroPace, Inc. and Shoulder Innovations, Inc. are of similar size ($435.6M and $424.1M). Shoulder Innovations, Inc. grew revenue faster over the last twelve months: 59.8% against 11.6%. NeuroPace, Inc. has the higher net margin (−19.3% vs −51.7%) and the higher return on invested capital (−44.6% vs −53.6%). Across the 17 metrics below, NeuroPace, Inc. leads on 11 and Shoulder Innovations, Inc. on 6.
Valuation
Profitability
| Metric | NPCE | SI | Medical Devices median |
|---|---|---|---|
| Gross margin | 81.57% | 77.82% | 57.76% |
| Operating margin | (13.87%) | (54.44%) | (15.07%) |
| Net margin | (19.34%) | (51.72%) | (14.45%) |
| Free cash flow margin | (11.75%) | (66.19%) | (3.88%) |
| Return on equity | (122.05%) | (25.05%) | (10.35%) |
| Return on assets | (18.82%) | (20.63%) | (17.26%) |
| Return on invested capital | (44.64%) | (53.60%) | (5.27%) |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack